Concepedia

Nannan Kang

NK

11

Publications

657

Citations

10

H-Index

2018

Active since

Affiliations

China Pharmaceutical University(Current)

Nanjing Drum Tower Hospital

Nanjing University

Nanjing Medical University

Nannan Kang is an author at China Pharmaceutical University specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

2018–2022

11

Publications

11

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

Jun Wei, Anantha Marisetty, Brett Schrand et al. · Journal of Clinical Investigation · 2018 · 391 citations · Full text

, , +23

MicroRNA-181a promotes follicular granulosa cell apoptosis via sphingosine-1-phosphate receptor 1 expression downregulation†

Chunxue Zhang, Jingtao Shen, Shuangbo Kong et al. · Biology of Reproduction · 2019 · 60 citations

Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer

Yu Liu, Xuemei Ji, Nannan Kang et al. · Cell Death and Disease · 2020 · 59 citations · Full text

A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy

Qiao Zheng, Xiaoping Li, Nannan Kang et al. · International Journal of Molecular Sciences · 2019 · 40 citations · Full text

Endometrial stromal PRMT5 plays a crucial role in decidualization by regulating NF-κB signaling in endometriosis

Xinyu Cai, Manlin Xu, Hui Zhang et al. · Cell Death Discovery · 2022 · 19 citations · Full text

, , +30

Rows per page

1–5 of 11